Sakaitani; Masahiro

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sakaitani; Masahiro.The latest application filed is for "biaryl sulfonamide derivative having filovirus cell entry inhibition activity".

Company Profile

1.13.10

Sakaitani; Masahiro - Sapporo-shi Hokkaido
Sakaitani; Masahiro - Hokkaido JP
Sakaitani; Masahiro - Kamakura N/A JP
Sakaitani; Masahiro - Shizuoka JP
Sakaitani; Masahiro - Kamakura-shi JP
Sakaitani; Masahiro - Kanagawa JP
Sakaitani; Masahiro - Chigasaki JP
Sakaitani; Masahiro - Chigasaki-shi JP
Sakaitani; Masahiro - Osaka JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biaryl Sulfonamide Derivative Having Filovirus Cell Entry Inhibition Activity App 20210107871 - Takada; Ayato ; et al.	2021-04-15
Quinazolinone and isoquinolinone derivative Grant 10,005,739 - Murata , et al. June 26, 2	2018-06-26
Quinazolinone And Isoquinolinone Derivative App 20160272595 - MURATA; Takeshi ; et al.	2016-09-22
p27 protein inducer Grant 8,569,378 - Sakai , et al. October 29, 2	2013-10-29
Coumarin derivative having antitumor activity Grant 8,278,465 - Iikura , et al. October 2, 2	2012-10-02
Glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes Grant 7,943,748 - Matsuoka , et al. May 17, 2	2011-05-17
Novel Coumarin Derivative Having Antitumor Activity App 20110092700 - Iikura; Hitoshi ; et al.	2011-04-21
Coumarin derivative having antitumor activity Grant 7,897,792 - Iikura , et al. March 1, 2	2011-03-01
.alpha.-amino acid derivatives and medicaments containing the same as an active ingredient Grant 7,879,887 - Ohrai , et al. February 1, 2	2011-02-01
p27 Protein Inducer App 20110009398 - Sakai; Toshiyuki ; et al.	2011-01-13
Novel Coumarin Derivative Having Antitumor Activity App 20100004233 - Iikura; Hitoshi ; et al.	2010-01-07
Alpha-amino Acid Derivatives And Medicaments Containing The Same As An Active Ingredient App 20090275623 - Ohrai; Kazuhiko ; et al.	2009-11-05
Novel Glucitol Derivative, Prodrug Thereof And Salt Thereof, And Therapeutic Agent Containing The Same For Diabetes App 20080319047 - Matsuoka; Hiroharu ; et al.	2008-12-25
N-substituted carbamoyloxyalkyl-azolium derivatives Grant 7,459,561 - Fukuda , et al. December 2, 2	2008-12-02
N-phenyl substituted carbamoyloxyalkyl-azolium derivatives Grant 7,189,858 - Fukuda , et al. March 13, 2	2007-03-13
N-substituted carbamoyloxyalkyl-azolium derivatives App 20070027322 - Fukuda; Hiroshi ; et al.	2007-02-01
Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives Grant 7,151,182 - Fukuda , et al. December 19, 2	2006-12-19
Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives App 20050038075 - Fukuda, Hiroshi ; et al.	2005-02-17
N-phenyl substituted carbamoyloxyalkyl-azolium derivatives App 20050038038 - Fukuda, Hiroshi ; et al.	2005-02-17
N-substituted carbamoyloxyalkyl-azolium derivatives Grant 6,812,238 - Fukuda , et al. November 2, 2	2004-11-02
Tertiary-butyldimethylsilyl carbamate derivative and process for producing the same Grant 4,837,349 - Ohfune , et al. June 6, 1	1989-06-06
Process for producing statin and related compounds Grant 4,803,292 - Ohfune , et al. February 7, 1	1989-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.